ZNTL
Zentalis Pharmaceuticals, Inc.Company with tickers: ZNTL
CIK
1725160
CUSIP
98943L107
Shares Outstanding
71,186,348
Website
https://www.zentalis.com
Investor Relations
https://ir.zentalis.com/overview/default.aspx
13F Activity (30d)
2 filings
1 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-02-11 | Cam Gallagher | Former Director, Former President & Interim CFO | 687 | 2025-02-11 | Morgan Stanley Smith Barney LLC |
| 2025-02-03 | Mark Lackner | Chief Scientific Officer | 14,368 | 2025-02-03 | Morgan Stanley Smith Barney LLC |
| 2025-02-03 | Andrea Paul | Chief Legal Officer & Corporate Secretary | 13,230 | 2025-02-03 | Morgan Stanley Smith Barney LLC |
| 2025-02-03 | Cam Gallagher | Former Director, Former President & Interim CFO | 28,558 | 2025-02-03 | Morgan Stanley Smith Barney LLC |
| 2024-10-31 | Diana Hausman | Former Chief Medical Officer | 9,888 | 2024-10-31 | Morgan Stanley Smith Barney LLC |
| 2024-05-31 | Cam Gallagher | Director, Officer - President & Interim CFO | 9,597 | 2024-05-31 | Morgan Stanley Smith Barney LLC |
| 2024-05-09 | Diana Hausman | Chief Medical Officer | 3,356 | 2024-05-09 | Morgan Stanley Smith Barney LLC |
| 2024-02-12 | Kevin Bunker | Former Chief Scientific Officer | 5,478 | 2024-02-12 | Morgan Stanley Smith Barney LLC |
| 2024-02-12 | Cam Gallagher | President, Director | 1,173 | 2024-02-12 | Morgan Stanley Smith Barney LLC |
| 2024-02-12 | Melissa Epperly | Chief Financial Officer | 2,573 | 2024-02-12 | Morgan Stanley Smith Barney LLC |
| 2024-02-02 | Andrea Paul | Chief Legal Officer and Corporate Secretary | 3,310 | 2024-02-02 | Morgan Stanley Smith Barney LLC |
| 2024-02-02 | Cam Gallagher | President, Director | 11,552 | 2024-02-02 | Morgan Stanley Smith Barney LLC |
| 2024-02-02 | Melissa Epperly | Chief Financial Officer | 8,669 | 2024-02-02 | Morgan Stanley Smith Barney LLC |
| 2024-02-02 | Mark Lackner | Chief Scientific Officer | 1,585 | 2024-02-02 | Morgan Stanley Smith Barney LLC |
| 2024-02-02 | Carrie Brownstein | Former Chief Medical Officer | 2,059 | 2024-02-02 | Morgan Stanley Smith Barney LLC |
| 2024-02-02 | Kevin Bunker | Former Chief Scientific Officer | 11,109 | 2024-02-02 | Morgan Stanley Smith Barney LLC |
| 2023-10-04 | Melissa Epperly | Chief Financial Officer | 5,482 | 2023-10-04 | Morgan Stanley Smith Barney LLC |
| 2023-10-04 | Kevin Bunker | Chief Scientific Officer | 6,068 | 2023-10-04 | Morgan Stanley Smith Barney LLC |
| 2023-10-04 | Carrie Brownstein | Chief Medical Officer | 10,628 | 2023-10-04 | Morgan Stanley Smith Barney LLC |
| 2023-09-11 | JAN SKVARKA | Director | 5,000 | 2023-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-05-31 | Cam Gallagher | Director, Officer - President | 9,242 | 2023-05-31 | Morgan Stanley Smith Barney LLC |
| 2023-05-31 | CAM GALLAGHER | Director, Officer | 18,526 | 2023-05-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–22 of 22 filings